David E. Morse
Impact in
-
- Lung Cancer Treatments and Mutations
- Renal cell carcinoma treatment
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Smoking Behavior and Cessation 5
-
- Gastrointestinal Tumor Research and Treatment 2
- Co-authors
- Richard Pazdur (9 shared papers)Neil E. Grunberg (5 shared papers)Robert L. Justice (6 shared papers)Rajeshwari Sridhara (6 shared papers)Brian P. Booth (6 shared papers)Sophia Abraham (4 shared papers)Deborah J. Bowen (1 shared paper)Ramzi N. Dagher (3 shared papers)
- Journals
- Clinical Cancer Research (8 papers)Psychopharmacology (4 papers)The Oncologist (1 paper)American Journal of Epidemiology (1 paper)Journal of Applied Social Psychology (1 paper)
- Partner nations
- United States
In The Last Decade
David E. Morse
18 papers receiving 2.9k citations
David E. Morse's Hit Papers
Peers
Comparison fields: 5 of 95
- Pulmonary and Respiratory Medicine 514
- Hematology 219
- Pharmacology 150
- Gastroenterology 95
- Oncology 280
Countries citing papers authored by David E. Morse
This map shows the geographic impact of David E. Morse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Morse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Morse more than expected).
Fields of papers citing papers by David E. Morse
This network shows the impact of papers produced by David E. Morse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Morse. The network helps show where David E. Morse may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Morse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 441 | |
| 2 | Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma Hit paper breakdown → | 2007 | 433 |
| 3 | 2006 | 417 | |
| 4 | 2004 | 298 | |
| 5 | 2007 | 233 | |
| 6 | 2007 | 222 | |
| 7 | 2008 | 209 | |
| 8 | 1984 | 207 | |
| 9 | 1994 | 103 | |
| 10 | 2005 | 94 | |
| 11 | 2006 | 78 | |
| 12 | 1996 | 59 | |
| 13 | 1991 | 58 | |
| 14 | Fulvestrant in postmenopausal women with advanced breast cancer. | 2003 | 48 |
| 15 | 1989 | 38 | |
| 16 | 1984 | 30 | |
| 17 | 1987 | 24 | |
| 18 | 1983 | 6 | |
| 19 | 1992 | 0 |
About David E. Morse
David E. Morse is a scholar working on Physiology, Gastroenterology, Pulmonary and Respiratory Medicine, Hematology and Behavioral Neuroscience, having authored 19 papers that have together received 3k indexed citations. Recurring topics across this work include Smoking Behavior and Cessation (5 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Nicotinic Acetylcholine Receptors Study (2 papers), Lung Cancer Treatments and Mutations (1 paper), Fluoride Effects and Removal (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Neurotransmitter Receptor Influence on Behavior (1 paper) and HIV/AIDS drug development and treatment (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (514 citations), Hematology (219 citations), Pharmacology (150 citations), Gastroenterology (95 citations) and Oncology (280 citations). David E. Morse has collaborated with scholars based in United States. Frequent co-authors include Richard Pazdur, Neil E. Grunberg, Robert L. Justice, Rajeshwari Sridhara, Brian P. Booth, Sophia Abraham, Deborah J. Bowen, Ramzi N. Dagher, Vicki L. Goodman and Nallaperumal Chidambaram. Their work appears in journals such as Clinical Cancer Research, Psychopharmacology, The Oncologist, American Journal of Epidemiology and Journal of Applied Social Psychology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.